How Much Does Zepbound Cost? (2026)
Zepbound (tirzepatide) by Eli Lilly is FDA-approved for chronic weight management and has demonstrated up to 22.5% average body weight loss in clinical trials. Here's every pricing option available in 2026 — including the LillyDirect self-pay program that makes it cheaper than most GLP-1 alternatives.
Quick Answer
Zepbound List Price Breakdown
Zepbound is manufactured by Eli Lilly and FDA-approved for chronic weight management in adults with a BMI of 30+ (obesity) or 27+ (overweight) with at least one weight-related condition. It contains tirzepatide, which activates both GLP-1 and GIP receptors — a dual mechanism that clinical trials show produces greater weight loss than semaglutide alone.
The wholesale acquisition cost (WAC) varies by dose:
- 2.5 mg (starting dose, weeks 1-4): $1,060/month
- 5 mg (maintenance): $1,060/month
- 7.5 mg (escalated): $1,060/month
- 10 mg (escalated): $1,060/month
- 12.5 mg (escalated): $1,060/month
- 15 mg (maximum dose): $1,060/month
Like Ozempic, all doses carry the same list price. At retail pharmacy without any discounts, you will pay approximately $1,060/month. However, Eli Lilly has taken a dramatically different approach to pricing than Novo Nordisk, offering aggressive self-pay programs that make Zepbound one of the most affordable brand-name GLP-1 options.
LillyDirect Self-Pay Program
Eli Lilly's LillyDirectprogram is the single biggest reason Zepbound has become the go-to choice for self-pay patients. Here's how it works:
How It Works
- --Visit LillyDirect.com or go through a partner telehealth provider
- --Complete an online consultation with a licensed prescriber
- --Pay $349/month for Zepbound at any dose level
- --Medication shipped directly to your home
Key Details
- --Price: $349/month (all doses)
- --Eligibility: Anyone without insurance coverage for Zepbound
- --No income requirement — available to all self-pay patients
- --Same FDA-approved medication as retail Zepbound
Why this matters: At $349/month, Zepbound via LillyDirect is $649 cheaper than Ozempic at list price ($998/month), $1,000 cheaper than Wegovy at list price ($1,349/month), and potentially more effective based on head-to-head clinical data. For self-pay patients, LillyDirect has fundamentally changed the GLP-1 pricing landscape.
Zepbound Cost With Insurance
Insurance coverage for Zepbound has improved significantly since its November 2023 launch, though coverage remains inconsistent across plans:
Preferred Commercial Plans
$25–$50/moPlans where Zepbound is preferred for weight management. Combined with Lilly savings card, patients can pay as little as $25/month for up to 12 months.
Non-Preferred Plans
$100–$200/moPlans that cover Zepbound but at a higher tier. May require step therapy (failed diet/exercise documentation) or prior authorization.
Plans Without Coverage
$349/mo (LillyDirect)If your insurance doesn't cover Zepbound, use LillyDirect at $349/month. Do not pay the $1,060 list price at retail.
Medicare Part D
~$50/mo (from Jul 2026)Medicare will cover Zepbound for weight loss starting July 2026 under the bridge program. Estimated copay: $35-$50/month with prior authorization.
Pro tip: Some insurers cover Mounjaro (same drug, tirzepatide, diabetes indication) but not Zepbound. If you have type 2 diabetes, ask your doctor about Mounjaro — it may have better insurance coverage. See Mounjaro pricing.
Savings Cards and Discount Programs
Eli Lilly offers multiple programs to reduce the cost of Zepbound:
Zepbound Savings Card
As low as $25/moFor commercially insured patients whose plan covers Zepbound. Reduces copay to as little as $25/month. Valid for up to 12 months per year. Cannot combine with Medicare, Medicaid, or government insurance.
LillyDirect Self-Pay
$349/moFixed self-pay price for any Zepbound dose. Available to anyone without insurance coverage. Includes consultation and home delivery. No income requirements.
Lilly Cares PAP
Free medicationPatient Assistance Program for uninsured patients earning under 400% of the Federal Poverty Level ($62,400/year individual). Provides free Zepbound for qualifying patients.
Zepbound Single-Dose Vials
Starting at $399/moEli Lilly introduced single-dose vials at lower price points: 2.5mg at $399/month, 5mg at $549/month. Available through select pharmacies.
Full Price Comparison
Every way to get Zepbound or equivalent GLP-1 medication in 2026.
| Option | Monthly Cost | FDA Approved | How to Access | Notes |
|---|---|---|---|---|
Zepbound (retail) Tirzepatide injection | $1,060/mo | Yes | Retail pharmacy | List price, no discounts |
LillyDirect Self-Pay Tirzepatide injection | $349/mo | Yes | LillyDirect.com | Best self-pay value |
Zepbound + Savings Card Tirzepatide injection | $25–$50/mo | Yes | Retail + copay card | Commercial insurance only |
Single-Dose Vials (2.5mg) Tirzepatide injection | $399/mo | Yes | Select pharmacies | Starting dose only |
Lilly Cares PAP Tirzepatide injection | $0/mo | Yes | Manufacturer program | Income under $62,400/yr |
Medicare Part D Tirzepatide injection | ~$50/mo | Yes | Part D enrollment | Starts July 2026 |
Mounjaro (diabetes) Tirzepatide injection | $1,023/mo | Yes | Retail pharmacy | Same drug, diabetes indication |
Ozempic (retail) Semaglutide injection | $998/mo | Yes | Retail pharmacy | Different drug class |
Oral Wegovy Semaglutide tablet | $149/mo | Yes | Telehealth or retail | Oral semaglutide; less weight loss |
Prices are approximate and may vary by pharmacy and location. Last updated March 2026.
Medicare Coverage Starting July 2026
Zepbound is one of the medications specifically named in the Medicare GLP-1 bridge program launching July 1, 2026. This represents a major expansion of coverage for the approximately 7.4 million Medicare beneficiaries with obesity.
- Zepbound will be covered for weight management under Medicare Part D
- Estimated copay: $35-$50/month (vs $1,060 list or $349 LillyDirect)
- Prior authorization required: BMI documentation, failed lifestyle modifications
- No age-related dose restrictions — all doses from 2.5mg to 15mg expected to be covered
For Medicare beneficiaries currently paying $349/month through LillyDirect, the bridge program will reduce costs by approximately 85%. Contact your Part D plan for formulary updates expected in Q2 2026. Read our full Medicare GLP-1 coverage guide.
Zepbound vs Ozempic and Wegovy: Cost Comparison
Zepbound's pricing strategy is fundamentally different from Novo Nordisk's approach with Ozempic and Wegovy. Here is how they compare:
- Ozempic ($998/month list): No manufacturer self-pay program. Best self-pay pricing through telehealth at $199-$349/month. FDA-approved for diabetes only. See Ozempic pricing.
- Wegovy ($1,349/month list): Same semaglutide as Ozempic but for weight loss. Oral Wegovy available at $149/month for the starting dose, but Zepbound shows greater weight loss in clinical trials. See Wegovy pricing.
- Mounjaro ($1,023/month list): Same tirzepatide as Zepbound but for diabetes. If you have type 2 diabetes, Mounjaro may have better insurance coverage. See Mounjaro pricing.
Bottom line: For self-pay patients specifically seeking weight loss, Zepbound at $349/month through LillyDirect offers the best combination of clinical effectiveness and affordability among FDA-approved injectable GLP-1 medications.
Frequently Asked Questions
How much does Zepbound cost per month?
Is LillyDirect legitimate?
Is Zepbound better than Ozempic?
Does insurance cover Zepbound?
Can I switch from Ozempic to Zepbound?
Will Zepbound prices drop in 2026?
Compare GLP-1 Providers by Price
Find the lowest verified price for Zepbound, Ozempic, Wegovy, and other GLP-1 medications from telehealth providers we've reviewed.